Katherine A. Reifler, MD
Assistant Professor
Boston University Chobanian & Avedisian School of Medicine
Medicine
Infectious Diseases




Katherine Reifler, MD, received her medical degree from the University of Illinois College of Medicine in Chicago and her undergraduate degree from Harvard University. Before medical school, she worked on public health initiatives in Nicaragua, the Dominican Republic, and Peru. During medical school, she spent time in Kenya working on emergency care systems and HIV screening in emergency settings. These early global health experiences, along with clinical training at safety-net hospitals in Chicago and Boston, shaped her commitment to addressing tropical infectious diseases, migrant health, and health inequities.

She completed her internal medicine residency and infectious disease fellowship at Boston University/Boston Medical Center. During her training, she began research focused on Chagas disease in migrant populations and worked on clinician education to raise awareness of this neglected tropical disease. Although the COVID-19 pandemic temporarily paused this work, she contributed to several COVID-related research efforts during that time.

As a BU CHART Trainee and Research Fellow, Dr. Reifler resumed her focus on migrant health and Chagas disease, conducting research in both Boston and Bolivia under the mentorship of Drs. David Hamer, Daniel Bourque, Robert Gilman, and Deborah Cotton. In Bolivia, her research includes studying cardiomyopathy in patients with Trypanosoma cruzi and HIV coinfection. She also collaborates with the Hematology/Oncology department to study infectious disease screening practices, particularly for latent tuberculosis and strongyloidiasis, in high-risk patients prior to cancer treatment.

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Website       Copy PMIDs To Clipboard

  1. Reifler KA, Sharma SS, Bergren NA, Barnett ED, Chen LH, Goad JA, Macleod WB, Kogelman L, Hamer DH. Ready for takeoff? exploring United States health care providers' pretravel consultation priorities, gaps, barriers, and opportunities. Travel Med Infect Dis. 2025 Sep 30; 68:102911.View Related Profiles. PMID: 41038602; DOI: 10.1016/j.tmaid.2025.102911;
     
  2. Reifler K, Wheelock A, Hall SM, Dauphinais M, Roytburd S, Maiullari M, Salazar A, Maldonado A, West HM, Köhler JR, Barnett ED, Gopal DM, Hamer DH, Bourque DL. Antitrypanosomal therapy for Chagas disease: A single center experience with adverse drug reactions and strategies for enhancing treatment completion. PLoS Negl Trop Dis. 2025 Jul; 19(7):e0013218.View Related Profiles. PMID: 40622934; PMCID: PMC12233308; DOI: 10.1371/journal.pntd.0013218;
     
  3. Reifler K, Campbell JI, Barnett ED, Bourque DL, Hamer DH, Samra H, Camelo I. Diagnosing Chagas in Pregnancy and Childhood: What's Old and New. Clin Lab Med. 2025 Mar; 45(1):73-86.View Related Profiles. PMID: 39892939
     
  4. Reifler KA, Francoeur Smith T, Bodanapu G, Fagan M, Bourque DL, Sloan JM. Indolent infections in patients with hematologic malignancy: A single-center experience screening for tuberculosis and strongyloidiasis prior to cytotoxic therapy in Boston. Leuk Res Rep. 2024; 22:100489.View Related Profiles. PMID: 39659827; PMCID: PMC11629577; DOI: 10.1016/j.lrr.2024.100489;
     
  5. Wheelock A, Sandhu S, Reifler K, Carrion M, Bourque DL, Hamer DH, Hochberg NS. Improving Clinician Awareness of and Screening for Chagas Disease with an Educational Intervention. Am J Trop Med Hyg. 2024 Aug 07; 111(2):380-386.View Related Profiles. PMID: 38889732; PMCID: PMC11310624; DOI: 10.4269/ajtmh.23-0483;
     
  6. Reifler KA, Wheelock A, Hall SM, Salazar A, Hassan S, Bostrom JA, Barnett ED, Carrion M, Hochberg NS, Hamer DH, Gopal DM, Bourque D. Chagas cardiomyopathy in Boston, Massachusetts: Identifying disease and improving management after community and hospital-based screening. PLoS Negl Trop Dis. 2024 Jan; 18(1):e0011913.View Related Profiles. PMID: 38241361; PMCID: PMC10830043; DOI: 10.1371/journal.pntd.0011913;
     
  7. Reifler, K., Kytomaa, S., Miller, N., Bourque, D. Plasmodium species reactivation in the setting of COVID-19 infection. Ann of Intern Med Case Reports. 2023; 5(2).
  8. Sinha P, Reifler K, Rossi M, Sagar M. Coronavirus Disease 2019 Mitigation Strategies Were Associated With Decreases in Other Respiratory Virus Infections. Open Forum Infect Dis. 2021 Jun; 8(6):ofab105.View Related Profiles. PMID: 34514014; PMCID: PMC8083776; DOI: 10.1093/ofid/ofab105;
     
  9. Sagar M, Reifler K, Rossi M, Miller NS, Sinha P, White LF, Mizgerd JP. Recent endemic coronavirus infection is associated with less-severe COVID-19. J Clin Invest. 2021 01 04; 131(1).View Related Profiles. PMID: 32997649; PMCID: PMC7773342; DOI: 10.1172/JCI143380;
     

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 9 publications over 4 distinct years, with a maximum of 4 publications in 2024

YearPublications
20212
20231
20244
20252


2024 University of Texas Medical Branch: Tropical Medicine Symposium Travel Award
2024 Boston University Center on Emerging Infectious Diseases: Grant
2023 Boston Medical Center: Health Equity Accelerator Grant
2022 Massachusetts Infectious Disease Society: Finland Award
2021 American Committee on Clinical Tropical Medicine and Travelers’ Health: Clinical Research Award
2017 UIC College of Medicine: Gold Humanism Honor Society
Contact for Mentoring:

801 Massachusetts Ave
Boston MA 02118
Google Map


Reifler's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department